GMA-202

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameGMA-202
Drug Alias NameGMA-202
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-Endothelin receptor type AAnti-CD3
TargetsEndothelin receptor type AT cell surface glycoprotein CD3
Therapy Area/IndicationsProstatic NeoplasmsOvarian NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGmax Biopharm Llc
China Registration ClassN/A

Develop Information

Active CompaniesGmax Biopharm Llc
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsOvarian NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A